HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain

  1. Edgar E Boczek
  2. Julius Fürsch
  3. Marie Laura Niedermeier
  4. Louise Jawerth
  5. Marcus Jahnel
  6. Martine Ruer-Gruß
  7. Kai-Michael Kammer
  8. Peter Heid
  9. Laura Mediani
  10. Jie Wang
  11. Xiao Yan
  12. Andrej Pozniakovski
  13. Ina Poser
  14. Daniel Mateju
  15. Lars Hubatsch
  16. Serena Carra
  17. Dr. Simon Alberti
  18. Anthony A Hyman
  19. Florian Stengel  Is a corresponding author
  1. Max Planck Institute of Molecular Cell Biology and Genetics, Germany
  2. University of Konstanz, Germany
  3. Max Planck Institute for the Physics of Complex Systems, Germany
  4. Biotec, TU Dresden, Germany
  5. University of Modena and Reggio Emilia, Italy

Abstract

Aberrant liquid-to-solid phase transitions of biomolecular condensates have been linked to various neurodegenerative diseases. However, the underlying molecular interactions that drive aging remain enigmatic. Here, we develop quantitative time-resolved crosslinking mass spectrometry to monitor protein interactions and dynamics inside condensates formed by the protein fused in sarcoma (FUS). We identify misfolding of the RNA recognition motif (RRM) of FUS as a key driver of condensate ageing. We demonstrate that the small heat shock protein HspB8 partitions into FUS condensates via its intrinsically disordered domain and prevents condensate hardening via condensate-specific interactions that are mediated by its α-crystallin domain (αCD). These αCD-mediated interactions are altered in a disease-associated mutant of HspB8, which abrogates the ability of HspB8 to prevent condensate hardening. We propose that stabilizing aggregation-prone folded RNA-binding domains inside condensates by molecular chaperones may be a general mechanism to prevent aberrant phase transitions.

Data availability

All data generated or analysed during this study are included in this published article (and its supplementary information files). The MS data (raw files, xQuest, xTract and in-house quantitation output files) have been deposited to the ProteomeXchange Consortium via the PRIDE (60) partner repository with the dataset identifier PXD021114 (Username: reviewer33076@ebi.ac.uk; Password: 5atfkbP8) and PXD021115 (Username: reviewer54149@ebi.ac.uk; Password: UZW7Gnr5).

The following data sets were generated

Article and author information

Author details

  1. Edgar E Boczek

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Edgar E Boczek, is currently an employee of Dewpoint Therapeutics..
  2. Julius Fürsch

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  3. Marie Laura Niedermeier

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  4. Louise Jawerth

    Max Planck Institute for the Physics of Complex Systems, Dresden, Germany
    Competing interests
    No competing interests declared.
  5. Marcus Jahnel

    Biophysics, Biotec, TU Dresden, Dresden, Germany
    Competing interests
    No competing interests declared.
  6. Martine Ruer-Gruß

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  7. Kai-Michael Kammer

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  8. Peter Heid

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  9. Laura Mediani

    University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    No competing interests declared.
  10. Jie Wang

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  11. Xiao Yan

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  12. Andrej Pozniakovski

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  13. Ina Poser

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Ina Poser, is currently an employee of Dewpoint Therapeutics.
  14. Daniel Mateju

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    No competing interests declared.
  15. Lars Hubatsch

    Max Planck Institute for the Physics of Complex Systems, Dresden, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1934-7437
  16. Serena Carra

    University of Modena and Reggio Emilia, Modena, Italy
    Competing interests
    No competing interests declared.
  17. Dr. Simon Alberti

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Dr. Simon Alberti, is a shareholder, consultant and member of the scientific advisory board for Dewpoint Therapeutics..
  18. Anthony A Hyman

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    Anthony A Hyman, is cofounder, shareholder, consultant and member of the scientific advisory board for Dewpoint Therapeutics..
  19. Florian Stengel

    Department of Biology, University of Konstanz, Konstanz, Germany
    For correspondence
    Florian.Stengel@uni-konstanz.de
    Competing interests
    Florian Stengel, is a consultant and member of the scientific advisory board for Dewpoint Therapeutics..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1447-4509

Funding

Deutsche Forschungsgemeinschaft (STE 2517/1-1)

  • Florian Stengel

Konstanz Research School Chemical Biology (Chemicals and small Equipment Purchase)

  • Florian Stengel

Deutsche Forschungsgemeinschaft (Cluster of Excellence Physics of Life"")

  • Dr. Simon Alberti

Deutsche Forschungsgemeinschaft (Cluster of Excellence Physics of Life"")

  • Anthony A Hyman

EU Joint Programme – Neurodegenerative Disease Research (Neurodegenerative Disease Research (JPND))

  • Serena Carra

EU Joint Programme – Neurodegenerative Disease Research (Neurodegenerative Disease Research (JPND))

  • Dr. Simon Alberti

AriSLA Foundation (Granulopathy and MLOpathy)

  • Serena Carra

MAECI (Dissolve_ALS)

  • Serena Carra

MIUR (E91I18001480001)

  • Serena Carra

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Boczek et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Edgar E Boczek
  2. Julius Fürsch
  3. Marie Laura Niedermeier
  4. Louise Jawerth
  5. Marcus Jahnel
  6. Martine Ruer-Gruß
  7. Kai-Michael Kammer
  8. Peter Heid
  9. Laura Mediani
  10. Jie Wang
  11. Xiao Yan
  12. Andrej Pozniakovski
  13. Ina Poser
  14. Daniel Mateju
  15. Lars Hubatsch
  16. Serena Carra
  17. Dr. Simon Alberti
  18. Anthony A Hyman
  19. Florian Stengel
(2021)
HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain
eLife 10:e69377.
https://doi.org/10.7554/eLife.69377

Share this article

https://doi.org/10.7554/eLife.69377

Further reading

    1. Biochemistry and Chemical Biology
    Adrian CD Fuchs
    Research Article

    The protein ligase Connectase can be used to fuse proteins to small molecules, solid carriers, or other proteins. Compared to other protein ligases, it offers greater substrate specificity, higher catalytic efficiency, and catalyzes no side reactions. However, its reaction is reversible, resulting in only 50% fusion product from two equally abundant educts. Here, we present a simple method to reliably obtain 100% fusion product in 1:1 conjugation reactions. This method is efficient for protein-protein or protein-peptide fusions at the N- or C-termini. It enables the generation of defined and completely labeled antibody conjugates with one fusion partner on each chain. The reaction requires short incubation times with small amounts of enzyme and is effective even at low substrate concentrations and at low temperatures. With these characteristics, it presents a valuable new tool for bioengineering.

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.